Quick answers
- What is Qudexy XR?
- Qudexy XR is a brand name of Topiramate, a prescription medicine. The FDA NDC Directory lists 5 Qudexy XR products in 5 strengths and forms.
- Who makes Qudexy XR?
- Upsher Smith Labs holds the FDA application for Qudexy XR (NDA205122, approved March 11, 2014).
- Is there a generic or store brand of Qudexy XR?
- Yes. The FDA NDC Directory lists 84 other products with the same active ingredients, strength and form as a Qudexy XR product, 80 of them generic. Ask your pharmacist whether one is right for you.
- Has Qudexy XR been recalled?
- No recall linked to Qudexy XR products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Qudexy XR is
Each Qudexy XR product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Topiramate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| topiramate 100 mg capsule, extended release (oral) | Qudexy XR | 19 products, 16 companies | DailyMed |
| topiramate 150 mg capsule, extended release (oral) | Qudexy XR | 8 products, 8 companies | DailyMed |
| topiramate 200 mg capsule, extended release (oral) | Qudexy XR | 19 products, 16 companies | DailyMed |
| topiramate 25 mg capsule, extended release (oral) | Qudexy XR | 19 products, 16 companies | DailyMed |
| topiramate 50 mg capsule, extended release (oral) | Qudexy XR | 19 products, 16 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Topiramate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA205122 | Upsher Smith Labs | March 11, 2014 | 5 |
Companies that list Qudexy XR
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Qudexy XR products.
- Upsher-Smith Laboratories, LLC5 products
Recalls
No recall linked to Qudexy XR products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.